Assignee
ABSCI CORP
US·4 granted patents·15 pending applications·0 citations·filing 2018–2024
Top patents by PatentIndex Score
19 records- 0183US2023340501A1Coordinated coexpression of thrombinABSCI CORP·Filed 2023·Application pending·0 cites
- 0268US2024263209A1Composition of transfer rnas and use in production of proteins containing non-standard amino acidsABSCI CORP·Filed 2024·Application pending·0 cites
- 0364US2023407363A1tRNA SYNTHETASES AND METHODS OF USE THEREOFABSCI CORP·Filed 2023·Application pending·0 cites
- 0464US2025092155A1Cancer associated antibody compositions and methods of useABSCI CORP·Filed 2024·Application pending·0 cites
- 0563US2025051760A1Solid-phase screening for high-performing bacterial strainsABSCI CORP·Filed 2022·Application pending·0 cites
- 0662US2025059259A1KNOCKOUT OF ptsP GENE ELEVATES ACTIVE GENE EXPRESSIONABSCI CORP·Filed 2022·Application pending·0 cites
- 0761US2025051758A1FolA Selection Assay to Identify Strains with Increased Soluble Target Protein ExpressionABSCI CORP·Filed 2022·Application pending·0 cites
- 0856US2025051823A1Products and methods for heterologous expression of proteins in a host cellABSCI CORP·Filed 2022·Application pending·0 cites
- 0954US12473370B2TL1A associated antibody compositions and methods of useABSCI CORP·Filed 2024·Granted Nov 18, 2025·0 cites·23 claims
- 1054US2023062579A1Activity-specific cell enrichmentABSCI CORP·Filed 2021·Application pending·0 cites
- 1153US12134655B2Cancer associated antibody compositions and methods of useABSCI CORP·Filed 2020·Granted Nov 5, 2024·0 cites·9 claims
- 1253US2025383346A1Affinity screening methodABSCI CORP·Filed 2023·Application pending·0 cites
- 1352US12157766B2Cytoplasmic expression systemABSCI CORP·Filed 2018·Granted Dec 3, 2024·0 cites·23 claims
- 1450US2023084052A1Proximity assayABSCI CORP·Filed 2021·Application pending·0 cites
- 1549US2025218531A1Unlocking de novo antibody design with generative artificial intelligenceABSCI CORP·Filed 2023·Application pending·0 cites
- 1648US2025104804A1Systems and methods of developing disease associated antibody sequencesABSCI CORP·Filed 2021·Application pending·0 cites
- 1746US12285484B2Cancer associated antibody compositions and methods of useABSCI CORP·Filed 2019·Granted Apr 29, 2025·0 cites·17 claims
- 1845US2023159598A1Polypeptide cleavage methodsABSCI CORP·Filed 2021·Application pending·0 cites
- 1944US2023268026A1Designing biomolecule sequence variants with pre-specified attributesABSCI CORP·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ABSCI CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →